Back

Prevalence and characteristics of transthyretin amyloid cardiomyopathy in patients with left ventricular hypertrophy in the TTRACK study: an interim analysis

21 May 2022 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Heart failure patient profile and outcome 1 Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2022

About the speaker

Photo
Doctor Pablo Garcia-Pavia

Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda (Spain)

6 More presentations in this session

Presentation thumbnail
Trajectories in New York Heart Association functional class across the ejection fraction spectrum: data from the Swedish Heart Failure registry
Mr F. Lindberg (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Persistent high burden of heart failure across the ejection fraction spectrum: data from the Swedish heart failure registry
Doctor D. Stolfo (Udine, IT)
Abstract Slides Video
Presentation thumbnail
The clinical impact of improved or decreased left ventricular systolic function after the initial attack in patients with acute myocardial infarction
Doctor S. Joo (Jeju, KR)
Abstract Slides Video
Presentation thumbnail
Health status trajectories before and after hospitalization for heart failure
Doctor M. Vaduganathan (Boston, US)
Abstract Slides Video
Presentation thumbnail
Risk prediction of advanced heart failure in arrhythmogenic cardiomyopathy
Doctor J. Segura-Aumente (Jaen, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Heart failure patient profile and outcome 1
Video

The Event

Event poster

Heart Failure 2022

21 May - 24 May 2022

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources